Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €59.95 EUR
Change Today +0.329 / 0.55%
Volume 2.0K
BRM On Other Exchanges
Symbol
Exchange
New York
Mexico
Sao Paulo
Frankfurt
As of 12:55 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for bristol-myers squibb co (BRM)

Year over year, Bristol-Myers Squibb Company has seen revenues fall from $16.4B USD to $15.9B USD. This along with an increase in income tax expense has led to a reduction in the bottom line from $2.6B USD to $2.0B USD.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Dec 31
2012
Dec 31
2013
Dec 31
2014
4 Year
Trend
Revenues21,244.017,621.016,385.015,879.0
TOTAL REVENUES21,244.017,621.016,385.015,879.0
Cost of Goods Sold5,523.04,554.04,842.03,781.0
GROSS PROFIT15,721.013,067.011,543.012,098.0
Selling General & Admin Expenses, Total5,131.04,932.04,923.04,717.0
R&D Expenses3,604.03,688.03,715.04,191.0
OTHER OPERATING EXPENSES, TOTAL8,735.08,620.08,638.08,908.0
OPERATING INCOME6,986.04,447.02,905.03,190.0
Interest Expense-145.0-182.0-199.0-203.0
Interest and Investment Income91.095.096.0100.0
NET INTEREST EXPENSE-54.0-87.0-103.0-103.0
Income (Loss) on Equity Investments281.0183.0166.0107.0
Other Non-Operating Income (Expenses)183.0305.0109.0420.0
EBT, EXCLUDING UNUSUAL ITEMS7,396.04,848.03,077.03,614.0
Merger & Restructuring Charges-221.0-499.0-282.0-379.0
Gain (Loss) on Sale of Investments--11.08.01.0
Gain (Loss) on Sale of Assets37.053.02.0564.0
Other Unusual Items, Total-231.0-2,073.086.0-1,419.0
Legal Settlements-6.045.0-20.0-23.0
Other Unusual Items-197.0-108.0106.0-1,024.0
EBT, INCLUDING UNUSUAL ITEMS6,981.02,340.02,891.02,381.0
Income Tax Expense1,721.0-161.0311.0352.0
Minority Interest in Earnings-1,551.0-541.0-17.0-25.0
Earnings from Continuing Operations5,260.02,501.02,580.02,029.0
NET INCOME3,709.01,960.02,563.02,004.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS3,701.01,959.02,563.02,004.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS3,701.01,959.02,563.02,004.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BRM:GR €59.95 EUR +0.329

BRM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AbbVie Inc $57.65 USD +0.38
Biogen Inc $429.87 USD +0.94
Celgene Corp $118.68 USD +1.02
Eli Lilly & Co $73.58 USD +0.14
Novo Nordisk A/S kr369.70 DKK +34.70
View Industry Companies
 

Industry Analysis

BRM

Industry Average

Valuation BRM Industry Range
Price/Earnings 54.4x
Price/Sales 6.8x
Price/Book 7.3x
Price/Cash Flow 54.3x
TEV/Sales 5.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BRISTOL-MYERS SQUIBB CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.